Evidence map›Paper›PMID 25222475›Full record

ArticlePloS one2014

Vitamin D deficiency aggravates chronic kidney disease progression after ischemic acute kidney injury.

Janaína Garcia Gonçalves, Ana Carolina de Bragança, Daniele Canale, Maria Heloisa Massola Shimizu, Talita Rojas Sanches, Rosa Maria Affonso Moysés, Lúcia Andrade, Antonio Carlos Seguro, Rildo Aparecido Volpini

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed, 1 pooled it
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 1 synthesis or guideline pooled it, 81 citations in OpenAlex.

  1. Pooled it
  2. Megalin: from structure to function.Nature reviews. Nephrology · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Observational
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Janaína Garcia GonçalvesNephrology Department, University of São Paulo School of Medicine, São Paulo, Brazil.
Ana Carolina de BragançaNephrology Department, University of São Paulo School of Medicine, São Paulo, Brazil.
Daniele CanaleNephrology Department, University of São Paulo School of Medicine, São Paulo, Brazil.
Maria Heloisa Massola ShimizuNephrology Department, University of São Paulo School of Medicine, São Paulo, Brazil.
Talita Rojas SanchesNephrology Department, University of São Paulo School of Medicine, São Paulo, Brazil.
Rosa Maria Affonso MoysésNephrology Department, University of São Paulo School of Medicine, São Paulo, Brazil.
Lúcia AndradeNephrology Department, University of São Paulo School of Medicine, São Paulo, Brazil.
Antonio Carlos SeguroNephrology Department, University of São Paulo School of Medicine, São Paulo, Brazil.
Rildo Aparecido VolpiniNephrology Department, University of São Paulo School of Medicine, São Paulo, Brazil.
Universidade de São Paulo · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDespite a significant improvement in the management of chronic kidney disease (CKD), its incidence and prevalence has been increasing over the years. Progressive renal fibrosis is present in CKD and involves the participation of several cytokines, including Transforming growth factor-β1 (TGF-β1). Besides cardiovascular diseases and infections, several studies show that Vitamin D status has been considered as a non-traditional risk factor for the progression of CKD. Given the importance of vitamin D in the maintenance of essential physiological functions, we studied the events involved in the chronic kidney disease progression in rats submitted to ischemia/reperfusion injury under vitamin D deficiency (VDD).

methodsRats were randomized into four groups: Control; VDD; ischemia/reperfusion injury (IRI); and VDD+IRI. At the 62 day after sham or IRI surgery, we measured inulin clearance, biochemical variables and hemodynamic parameters. In kidney tissue, we performed immunoblotting to quantify expression of Klotho, TGF-β, and vitamin D receptor (VDR); gene expression to evaluate renin, angiotensinogen, and angiotensin-converting enzyme; and immunohistochemical staining for ED1 (macrophages), type IV collagen, fibronectin, vimentin, and α-smooth mucle actin. Histomorphometric studies were performed to evaluate fractional interstitial area.

resultsIRI animals presented renal hypertrophy, increased levels of mean blood pressure and plasma PTH. Furthermore, expansion of the interstitial area, increased infiltration of ED1 cells, increased expression of collagen IV, fibronectin, vimentin and α-actin, and reduced expression of Klotho protein were observed. VDD deficiency contributed to increased levels of plasma PTH as well as for important chronic tubulointerstitial changes (fibrosis, inflammatory infiltration, tubular dilation and atrophy), increased expression of TGF-β1 and decreased expression of VDR and Klotho protein observed in VDD+IRI animals.

conclusionThrough inflammatory pathways and involvement of TGF-β1 growth factor, VDD could be considered as an aggravating factor for tubulointerstitial damage and fibrosis progression following acute kidney injury induced by ischemia/reperfusion.

Indexed as

ActinsAcute Kidney InjuryAngiotensinogenAnimalsDisease ProgressionFibronectinsKidneyMaleRatsRats, WistarReceptors, CalcitriolRenal Insufficiency, ChronicReninReperfusion InjuryTransforming Growth Factor betaTransforming Growth Factor beta1ActinsAngiotensinogenFibronectinsReceptors, CalcitriolReninTransforming Growth Factor betaTransforming Growth Factor beta1

Identifiers

PMID25222475
PMCPMC4164619
OpenAlexW1965285810

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.